SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-045021
Filing Date
2021-02-16
Accepted
2021-02-16 16:39:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d129458dsc13ga.htm SC 13G/A 33618
  Complete submission text file 0001193125-21-045021.txt   34901
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Subject) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90350 | Film No.: 21639635
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
During Matthew (Filed by) CIK: 0001704631 (see all company filings)

Type: SC 13G/A